Skip to main navigation Skip to search Skip to main content

A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment. . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/13 → 01/1/16

Funding

  • Gilead Sciences Incorporated: $12,900.00